Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 16:05 ET | Source: electroCore, Inc.

electroCore Announces First Quarter 2025 Financial Results

First quarter 2025 net sales of $6.7 million, an increase of 23% over first quarter 2024 Closed the acquisition of NeuroMetrix, Inc. (“NeuroMetrix”); first quarter 2025 unaudited Quell net sales of...
February 06, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Expands Intellectual Property Portfolio

ROCKAWAY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received two patent...
February 04, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th...
September 24, 2024 08:00 ET | Source: electroCore, Inc.

electroCore Engages FNK IR to Execute Expanded Investor Relations Program

ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...
June 03, 2024 08:30 ET | Source: electroCore, Inc.

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced...
March 05, 2024 16:05 ET | Source: electroCore, Inc.

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
October 05, 2023 08:00 ET | Source: electroCore, Inc.

electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference

ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
August 09, 2023 16:05 ET | Source: electroCore, Inc.

electroCore Announces Second Quarter 2023 Financial Results

Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second quarter 2022 Company to host a conference call and webcast today, August 9, 2023 at 4:30 PM EDT ...
September 29, 2022 06:00 ET | Source: UM6P Ventures (988809)

UM6P Ventures Invests in Infiuss Health to Improve Clinical Trial Participation and Health Equity in Africa

CASABLANCA, Morocco, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Today, UM6P Ventures announced its investment in Infiuss Health. The startup is developing a decentralized SaaS platform to power remote...